Skip to main content

PARP/PI3K-IN-1 (C007B-385486)

Catalog No.
C007B-385486
Mfr. No.
P647135-25mg
Mfr. Name
Aladdin Scientific
Qty/UOM
1
UOM
EA
Price: $1,871.18
List Price: $2,079.09

PARP/PI3K-IN-1 (compound 15) is a potent PARP/PI3K inhibitor with pIC 50 values of 8.22, 8.44, 8.25, 6.54, 8.13, 6.08 for PARP-1, PARP-2, PI3Kα , PI3Kβ , PI3Kδ , and PI3Kγ , respectively. PARP/PI3K-IN-1 is a highly effective anticancer compound

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Adding to cart… The item has been added
PARP/PI3K-IN-1 (compound 15) is a potent PARP/PI3K inhibitor with pIC 50 values of 8.22, 8.44, 8.25, 6.54, 8.13, 6.08 for PARP-1, PARP-2, PI3Kα , PI3Kβ , PI3Kδ , and PI3Kγ , respectively. PARP/PI3K-IN-1 is a highly effective anticancer compound targeted against a wide range of oncologic diseasesIn VitroPARP/PI3K-IN-1 (compound 15; 1 μM; 72 hours) leads to a significant increase in cell apoptosis. PARP/PI3K-IN-1 (1 μM; 72 hours) reduces the autophosphorylation levels of AKT and S6 while increases the autophosphorylation level of ERK after treating cells, indicating that it can inhibit the PI3K pathway and activate the ERK pathway. PARP/PI3K-IN-1 (1 μM) displays a strong capability to downregulate the expression of BRCA1/2 at the mRNA level in MDA-MB-468 cancer cells. PARP/PI3K-IN-1 not only shows significant inhibitory activity against BRCA-deficient cells HCC1937 and HCT116, but also displays potent anti-proliferative activity against BRCA-proficient cells MDA-MB-231 and MDA-MB-468. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Apoptosis AnalysisCell Line: MDA-MB-468 cancer cells Concentration: 1 μM Incubation Time: 72 hours Result: Led to a significant increase in cell apoptosis. Western Blot AnalysisCell Line: MDA-MB-468 cancer cells Concentration: 1 μM Incubation Time: 72 hours Result: Reduced the autophosphorylation levels of AKT and S6 while increased the autophosphorylation level of ERK after treating cells.In VivoPARP/PI3K-IN-1 (i.p.; 50 mg/kg; twice daily (BID) for 34 consecutive days) significantly suppresses the tumor growth . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Six-week-old male BALB/c nude mice with MDA-MB-468 cells Dosage: 50 mg/kg Administration: i.p.; twice daily (BID) for 34 consecutive days Result: Significantly suppressed the tumor growth.Form:SolidIC50& Target:PARP-1 8.22 (pIC 50 ) PARP-2 8.44 (pIC 50 ) PI3Kα 8.25 (pIC 50 ) PI3Kβ 6.54 (pIC 50 ) PI3Kδ 8.13 (pIC 50 ) PI3Kγ 6.08 (pIC 50 ). Specification: 0.98 Molecular Formula: C33H28F4N8O3 Molecular Weight: 660.62 PubChem CID: 156588977
UPC:
51111652
Condition:
New
Availability:
8-12 weeks
Weight:
1.06 Ounces
HazmatClass:
No
WeightUOM:
LB
MPN:
P647135-25mg
CAS:
2337386-47-5
Product Size:
25mg

Cenmed Satisfaction Guarantee
Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

Testimonial
"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR

Testimonial
"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER

Testimonial
"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN

Testimonial
"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.